Drop the hammer! National renewal varieties "big reversal", the new evaluation of enterprises to replace acceleration

With the deepening of national mining, many provinces have started to start the alliance procurement due renewal work, and is deeply affecting the future direction of the pharmaceutical industry.
January 29, Hubei Province drug procurement department issued a notice is helping to support the arrival of this trend: Hubei Province pharmaceutical prices and tender procurement management service network announced the national organization of drug centralized belt procurement pilot expansion (Hubei) Paroxetine oral regular release dosage form and other 8 varieties of the proposed results.
of the original selected enterprises were replaced to map out two distinct characteristics caused concern in the industry. On the basis of the selected price of
, the average price reduction of another 49% from this selection results, left ethyl laxitam tablets, Malay acid inapri tablets, hydrochloric acid right metomidin injections and other treatment of depression, cardiovascular disease, epilepsy, leukemia, asthma, tumors and other diseases of common drug selection prices have been reduced by different ranges.
overall, the average price of the pilot expansion was 49% lower than the previous pilot expansion.
industry has judged that the drug concentrated with volume procurement background renewal bid will be intensified.
Taking Hubei as an example, three batches of national drug collection results were implemented, with an average decrease of 67%;
Renewal means that there will be new competition will enter, the introduction of the original research or new evaluation varieties bid renewal, is not only to maintain fair competition in the market, but also a "reverse force", shorten the access cycle so that the market full competition to form a reasonable price, but also to give the strength to actively carry out consistent evaluation of enterprises to stimulate the overall level of the industry.
the new pattern behind the replacement of the renewal varieties this proposed result also sends an important signal: the above eight varieties, in addition to the Paroxitin tablets, the original central selection of Hubei enterprises were basically replaced.
, the new evaluation enterprises get the opportunity to quickly seize the market, and Fusinpri sodium tablets, Menglust sodium tablets and other original research enterprises in Hubei Province were also replaced.
Is not so much being replaced as the market has emerged a new seed: "Pharmaceutical Economics" has previously paid attention to the new round of bidding situation in Hubei (click to review), Hubei requirements, in order to ensure that enterprises, market expectations and price levels are relatively stable on the basis of the "first inquiry after bidding" approach to carry out this renewal and bidding work.
to encourage qualified original drug research enterprises and pilot expansion of the procurement cycle to collect the same product regulations of new evaluation of generic drug enterprises to actively participate.
to large varieties of hydrochloric acid right metomide injection as an example, the results let the industry see a new breath.
the first generic drug to be evaluated failed to keep the market and was replaced by a later one.
, the final selection of Hunan Colum Pharmaceuticals' hydrochloric acid right metomide injection has only been evaluated for 10 days.
, just before the company, Hengrui Pharmaceuticals received a notice of evaluation.
the first evaluation of enterprises, the product market rapidly released, in 2019 market sales of more than 1 billion yuan, the market share rose to 33%.
, in addition to Hubei, Heilongjiang, Guizhou, Shanxi, Xinjiang, Liaoning and other places have begun to carry out the renewal of national varieties.
, the fierce competition outside Hubei is expected to continue.
the knock-on effects of this will be exacerbated.
Hubei Province's approach also has another feature is that the original selection of enterprises to renew, the procurement cycle in principle for 1 year, and in accordance with the provisions of the signing of procurement agreements;
some in the industry believe that "it's easy to lose the market, it's harder to get it back."
, there is only one possibility left in the game.
" in addition, the left ethyl laxitan film, Malay acid Inapri film two varieties of over-evaluation of the number of enterprises, price competition is also very fierce.
, the renewal of contracts in other provinces is also expected to be a price war.